Merotik Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Meropenem

Indications/Uses

Pneumonia, UTI, intra-abdominal infections, gynecological infections (eg, endometritis), skin & soft tissue infections, meningitis, septicemia. Empiric treatment in adults w/ suspected febrile neutropenic infections.

Dosage/Direction for Use

Pneumonia, UTI, gynecologic infections, skin & skin structure infections 500 mg IV 8 hrly. Nosocomial pneumonia, peritonitis, suspected neutropenic infection, septicemia 1 g IV 8 hrly. Meningitis 2 g IV 8 hrly.

Contraindications

Hypersensitivity.

Special Precautions

Partial cross-allergic reactions w/ penicillins & cephalosporins. History of allergy. Liver disease, infections due to MRSA, GI complaints. Pregnancy & lactation. Infant <3 mth.

Adverse Reactions

Local inj site reactions, systemic allergic reactions, rash, pruritus, urticaria, erythema multiforme, SJS, TEN, abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis, reversible thrombocythemia, eosinophilia, thrombocytopenia, leucopenia, neutropenia. False +ve Coombs' test result; increased bilirubin, transaminase, alkaline phosphatase & serum LDH; headache, paresthesia, convulsion, oral & vag candidiasis.

View ADR Monitoring Form

Drug Interactions

Probenecid.

MIMS Class

Other Beta-Lactams

ATC Classification

J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

Merotik inj 0.5 g

Packing/Price

1's (Rp210,000/vial)

Form

Merotik inj 1 g

Packing/Price

1's (Rp330,000/vial)

Merotik

meropenem

Manufacturer:

Lapi